Maternal Serum Placental Growth Factor, Soluble Fms-Like Tyrosine Kinase-1, and Soluble Endoglin in Twin Gestations and the Risk of Preeclampsia-A Systematic Review

被引:10
作者
Kosinska-Kaczynska, Katarzyna [1 ]
Zgliczynska, Magdalena [1 ,2 ]
Kozlowski, Szymon [3 ]
Wicherek, Lukasz [1 ]
机构
[1] Ctr Postgrad Med Educ, Dept Obstet & Gynecol 2, PL-01809 Warsaw, Poland
[2] Med Univ Warsaw, Lab Ctr Preclin Res, Chair & Dept Expt & Clin Physiol, PL-02106 Warsaw, Poland
[3] Med Univ Warsaw, Univ Ctr Woman & Newborn Hlth, PL-02015 Warsaw, Poland
关键词
placental growth factor; serum soluble fms-like tyrosine kinase-1; endoglin; preeclampsia; prediction; twin pregnancy; SFLT-1/PLGF RATIO; HYPERTENSIVE DISORDERS; ANGIOGENIC FACTORS; PREDICTIVE-VALUE; PREGNANCIES; SINGLETON; OUTCOMES; WOMEN; 1ST; COMPLICATIONS;
D O I
10.3390/jcm9010183
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Multiple gestation is one of the key risk factors for the occurrence of preeclampsia (PE). Soluble fms-like tyrosine kinase-1, placental growth factor, and soluble endoglin are molecules involved in the process of angiogenesis with a proven role in the pathogenesis of PE. The aim of the review was to summarize available data on maternal serum levels of the above-mentioned factors and their usefulness in predicting PE in twin pregnancies. Only original research articles written in English were considered eligible. Reviews, chapters, case studies, conference papers, experts' opinions, editorials, and letters were excluded from the analysis. No publication date limitations were imposed. The systematic literature search using PubMed/MEDLINE, Scopus, Embase, and Cochrane Library databases identified 338 articles, 10 of which were included in the final qualitative analyses. The included studies showed significant differences in maternal serum levels of the discussed factors between women with twin pregnancies with PE and those who did not develop PE, and their promising performance in predicting PE, alone or in combination with other factors. The identification of the most effective algorithms, their prompt introduction to the clinical practice, and further assessment of the real-life performance should become a priority.
引用
收藏
页数:13
相关论文
共 50 条
[21]   Cord Blood Soluble fms-Like Tyrosine Kinase 1 and Placental Growth Factor in Preterm Infants with Maternal Preeclampsia [J].
Kim, Jiyoung ;
Cho, Sujin ;
Kim, Young Ju ;
Park, Hye Sook ;
Ha, Eun-Hee ;
Park, Eun Ae .
EWHA MEDICAL JOURNAL, 2013, 36 (02) :118-125
[22]   Disulfiram inhibits placental soluble FMS-like tyrosine kinase-1 and soluble endoglin secretion independent of the proteasome [J].
Hastie, Roxanne ;
Ye, Louie ;
Hannan, Natalie J. ;
Brownfoot, Fiona C. ;
Cannon, Ping ;
Nguyen, Vi ;
Tong, Stephen ;
Kaitu'u-Lino, Tu'uhevaha J. .
PREGNANCY HYPERTENSION-AN INTERNATIONAL JOURNAL OF WOMENS CARDIOVASCULAR HEALTH, 2018, 14 :125-130
[23]   In vivo uteroplacental release of placental growth factor and soluble Fms-like tyrosine kinase-1 in normal and preeclamptic pregnancies [J].
Holme, Ane M. ;
Roland, Marie C. P. ;
Henriksen, Tore ;
Michelsen, Trond M. .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2016, 215 (06)
[24]   Differential Diagnosis of Preeclampsia Remember the Soluble Fms-Like Tyrosine Kinase 1/Placental Growth Factor Ratio [J].
Verdonk, Koen ;
Visser, Willy ;
Russcher, Henk ;
Danser, A. H. Jan ;
Steegers, Eric A. P. ;
van den Meiracker, Anton H. .
HYPERTENSION, 2012, 60 (04) :884-890
[25]   Predictive value of soluble fms-like tyrosine kinase-1 against placental growth factor for preeclampsia in a Chinese pregnant women population [J].
Yu, Fan ;
Bai, Qianjin ;
Zhang, Shihong ;
Jiang, Yongmei .
JOURNAL OF CLINICAL LABORATORY ANALYSIS, 2019, 33 (05)
[26]   Stability of placental growth factor, soluble fms-like tyrosine kinase 1, and soluble fms-like tyrosine kinase 1 e15a in human serum and plasma [J].
Rowson, Saskia ;
Reddy, Maya ;
Rolnik, Daniel L. ;
Costa, Fabricio Da Silva ;
Palmer, Kirsten R. .
PLACENTA, 2019, 86 :1-3
[27]   Increased plasma soluble fms-like tyrosine kinase 1 and endoglin levels in pregnancies complicated with preeclampsia [J].
Chedraui, Peter ;
Lockwood, Charles J. ;
Schatz, Frederick ;
Buchwalder, Lynn F. ;
Schwager, Gino ;
Guerrero, Carlos ;
Escobar, Gustavo S. ;
Hidalgo, Luis .
JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE, 2009, 22 (07) :565-570
[28]   Serum soluble FMS-like tyrosine kinase 1 and placental growth factor concentration as predictors of preeclampsia in high risk pregnant women [J].
Hanita, O. ;
Alia, N. N. ;
Zaleha, A. M. ;
Azlin, M. I. Nor .
MALAYSIAN JOURNAL OF PATHOLOGY, 2014, 36 (01) :19-26
[29]   Inter-manufacturer comparison of automated immunoassays for the measurement of soluble FMS-like tyrosine kinase-1 and placental growth factor [J].
Yue, Cheng Yvonne Kwun ;
Yee, Poon Liona Chiu ;
Andrew, Shennan ;
Yeung, Leung Tak ;
Singh, Sahota Daljit .
PREGNANCY HYPERTENSION-AN INTERNATIONAL JOURNAL OF WOMENS CARDIOVASCULAR HEALTH, 2019, 17 :165-171
[30]   New Gestational Phase-Specific Cutoff Values for the Use of the Soluble fms-Like Tyrosine Kinase-1/Placental Growth Factor Ratio as a Diagnostic Test for Preeclampsia [J].
Verlohren, Stefan ;
Herraiz, Ignacio ;
Lapaire, Olav ;
Schlembach, Dietmar ;
Zeisler, Harald ;
Calda, Pavel ;
Sabria, Joan ;
Markfeld-Erol, Filiz ;
Galindo, Alberto ;
Schoofs, Katharina ;
Denk, Barbara ;
Stepan, Holger .
HYPERTENSION, 2014, 63 (02) :346-+